3.70
Hyperion Defi Inc stock is traded at $3.70, with a volume of 612.97K.
It is up +8.50% in the last 24 hours and up +14.91% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.
See More
Previous Close:
$3.41
Open:
$3.59
24h Volume:
612.97K
Relative Volume:
1.65
Market Cap:
$31.35M
Revenue:
$345.30K
Net Income/Loss:
$-25.50M
P/E Ratio:
-0.1718
EPS:
-21.5384
Net Cash Flow:
$-16.82M
1W Performance:
-1.86%
1M Performance:
+14.91%
6M Performance:
-56.26%
1Y Performance:
+0.00%
Hyperion Defi Inc Stock (HYPD) Company Profile
Name
Hyperion Defi Inc
Sector
Industry
Phone
833-393-6684
Address
295 MADISON AVENUE, NEW YORK
Compare HYPD vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HYPD
Hyperion Defi Inc
|
3.70 | 31.35M | 345.30K | -25.50M | -16.82M | -21.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
|
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-24-25 | Initiated | Chardan Capital Markets | Buy |
| Dec-16-25 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Hyperion Defi Inc Stock (HYPD) Latest News
Hyperion DeFi, Inc. Q4 earnings preview - MSN
Hyperion DeFi (HYPD) Set to Release Q4 Earnings Results - GuruFocus
Hyperion DeFi partners with Silhouette trading platform By Investing.com - Investing.com Australia
Hyperion DeFi (HYPD) Signs Agreement with Silhouette for Reduced Trading Fees - GuruFocus
Hyperion DeFi signs asset-use deal with Silhouette to lower trading fees - MSN
Hyperion DeFi partners with Silhouette trading platform - Investing.com
Hyperion DeFi Enters HAUS Agreement with Silhouette - marketscreener.com
Hyperion DeFi And Silhouette Enter HYPE Asset Use Service Agreement - marketscreener.com
Hyperliquid DATs Capture 7% Of HYPE Supply In Push To Replicate Strategy's Bitcoin Model - Stocktwits
Hyperion DeFi Schedules Fourth Quarter and Full Year 2025 Earnings Call for Thursday, March 26 at 8:00 a.m. ET - The Manila Times
Top Hyperion DeFi (HYPD) Competitors 2026 - MarketBeat
Why Hyperliquid Can Still 10X, According to the CEO of Digital Asset Treasury Company Hyperion DeFi - Yahoo Finance
Hyperion DeFi shares edge higher following Kinetiq airdrop and new partnership activity - MSN
Hyperion DeFi finalizes leadership team and equity conversion - MSN
Hyperion DeFi (HYPD) Collaborates with HyperLend for Innovative Lending Pool - GuruFocus
Private on-chain lending pool launches via HyperEVM, Hyperion DeFi outlines - Traders Union
Hyperion DeFi Announces Private Lending Pool Built by HyperLend - marketscreener.com
Zelira Therapeutics (OTCMKTS:ZLDAF) and Hyperion DeFi (NASDAQ:HYPD) Critical Analysis - Defense World
HYPD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Avanza Pension reports 10.19% stake in Hyperion DeFi (NASDAQ: HYPD) - Stock Titan
Hyperion DeFi leadership outlines conviction in next-generation financial infrastructure at NASDAQ - Traders Union
HYPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HYPD Technical Analysis & ETF Price Forecast - Intellectia AI
Faron Pharmaceuticals Oy (OTC:FPHAF) & Hyperion DeFi (NASDAQ:HYPD) Financial Contrast - Defense World
HYPD Should I Buy - Intellectia AI
HYPDHyperion DeFi Inc Latest Stock News & Market Updates - Stock Titan
MSN Money - MSN
Hyperion to expand options income using HYPE as collateral - 디지털투데이
Hyperion DeFi - Nasdaq
Hyperion DeFi Hyperliquid Treasuries: HYPD.US HYPE Holdings Chart, Purchase History & More - CoinGecko
Hyperion DeFi launches institutional yield vault on Hyperliquid By Investing.com - Investing.com Nigeria
Hyperliquid treasury seeks revenue boost using HYPE holdings as options collateral - The Block
Hyperion DeFi launches institutional yield vault on Hyperliquid - Investing.com
Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol - The Manila Times
Hyperion Defi, Inc. Announces Institutional Volatility Income Vault Built on Rysk Protocol - marketscreener.com
Hyperliquid roars past XRP, BNB with 65% rally: Why treasury companies buy the HYPE - MSN
Hyperliquid Roars Past XRP, BNB With 65% Rally: Why Treasury Companies Buy The HYPE - Benzinga
Hyperion DeFi (HYPD) Price Target Increased by 46.87% to 5.99 - Nasdaq
Hyperion DeFi Issues Letter to Shareholders - The Manila Times
Inside the first U.S. public company built around Hyperliquid DeFi - Stock Titan
Robert Rubenstein Net Worth (2026) - GuruFocus
Humacyte (NASDAQ:HUMAW) & Hyperion DeFi (NASDAQ:HYPD) Head to Head Analysis - Defense World
Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul By Investing.com - Investing.com Nigeria
Hyperion DeFi (NASDAQ:HYPD) CFO David Knox Acquires 27,950 Shares of Stock - Defense World
Hyperion DeFi Finalizes Leadership Team and Equity Conversion - TipRanks
Hyperion Defi, Inc. Appoints Robert Rubenstein as General Counsel, Effective January 6, 2026 - marketscreener.com
Hyperion DeFi appoints Hyunsu Jung as CEO to fully implement its 2026 strategic plan - Bitget
Hyperion DeFi appoints Hyunsu Jung as chief executive officer - marketscreener.com
Hyperion Defi Appoints Hyunsu Jung As Chief Executive Officer - TradingView — Track All Markets
Hyperion DeFi, Inc. Stock (HYPD) Opinions on New CEO Appointment and Stock Surge - Quiver Quantitative
Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul - Investing.com
Hyperion Defi Inc Stock (HYPD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hyperion Defi Inc Stock (HYPD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Strahlman Ellen R | Director |
Dec 29 '25 |
Buy |
3.60 |
12,112 |
43,603 |
91,161 |
| Strahlman Ellen R | Director |
Dec 29 '25 |
Buy |
3.61 |
11,856 |
42,800 |
34,869 |
| Strahlman Ellen R | Director |
Dec 26 '25 |
Buy |
3.86 |
3,601 |
13,911 |
79,049 |
| Strahlman Ellen R | Director |
Dec 26 '25 |
Buy |
3.86 |
3,311 |
12,777 |
23,013 |
| Strahlman Ellen R | Director |
Dec 18 '25 |
Buy |
3.14 |
19,702 |
61,835 |
95,150 |
| Strahlman Ellen R | Director |
Dec 18 '25 |
Buy |
3.14 |
18,742 |
58,829 |
75,448 |
| Walters Happy David | Director |
Dec 17 '25 |
Buy |
3.02 |
61,930 |
187,152 |
111,930 |
| GELTZEILER MICHAEL S | Director |
Dec 17 '25 |
Buy |
3.01 |
30,000 |
90,210 |
88,015 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):